Varicella Vaccine
Varicella vaccination administration schedule allows for flexibility
Published in Vaccine Weekly, June 25th, 2003
According to a study from Thailand, "A clinical trial to assess the immunogenicity and reactogenicity of two doses of varicella vaccine (live attenuated Oka-strain, GlaxoSmithlKline Biologicals), when either given eight or four weeks apart in healthy seronegative adolescents and young adults, was conducted in Khon Kaen and Bangkok, Thailand. Contrary to seroconversion rates generally reported for this age group, in our study all subjects were already seropositive after the first vaccine dose."
"After the first vaccine dose, geometric mean titers (GMTs) for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-06-25)
More Articles from Vaccine Weekly
- DNA Vaccine
Genes from replicative form of Trypanosoma cruzi protect mice - Microencapsulation
Acid-degradable microgels developed for protein-based vaccines - Atherosclerosis
Antibodies against heat shock proteins implicated in atherosclerosis - DNA Vaccine
Intramuscular and intradermal DNA vaccines elicit different immune responses - Malaria Vaccine
Oral malaria protein vaccine protects mice against lethal malaria challenge - Vaccine Delivery
Bacterial spores used as vaccine vehicles - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
